Canada Import Bans and Section 232 Pharma Tariffs: CBP Guidance

Key Points

• Three presidential proclamations (11061, 11062, 11063) exclude certain Canadian alcoholic beverages and other Canadian products from importation into the United States, effective 12:01 a.m. ET on September 29, 2026.
• CBP has added new error codes in ACE Cargo Release and for e214 Foreign Trade Zone (FTZ) admissions to enforce these restrictions on designated Canadian-origin goods.
• Affected goods that are entered for consumption or withdrawn from a warehouse for consumption on or after September 29, 2026 are subject to the new restrictions, regardless of when they arrived.
• Separately, CBP has issued updated guidance on Section 232 duties covering pharmaceutical articles and ingredients under Proclamation 11020, incorporating a September 23, 2026 Federal Register notice on specialty pharmaceuticals and technical HTS corrections.
• Importers, brokers, and FTZ operators must review ACE filing procedures and HTS classifications immediately to avoid rejection errors and duty miscalculations.

On this page

1. What changed: Canadian product import bans under Proclamations 11061, 11062, and 11063
2. New ACE and FTZ error codes for restricted Canadian goods
3. Dates and applicability for Canadian restrictions
4. Section 232 pharmaceutical tariffs: updated guidance under Proclamation 11020
5. Interaction with FTZ admissions and warehouse withdrawals
6. What importers, brokers, and compliance teams should do
7. Key references

On September 28, 2026, CBP issued three separate guidance messages covering two major trade actions: a set of presidential proclamations excluding certain Canadian products from importation into the United States, and updated implementation guidance for Section 232 tariffs on pharmaceutical articles and ingredients. Importers and brokers with Canadian-origin supply chains or pharmaceutical product lines need to act before the September 29, 2026 effective date for the Canadian restrictions and review current HTS classifications for pharma entries immediately.

The links in this article go to the primary documents: the proclamations, Federal Register notices, and official CBP guidance pages themselves. Read the source.

What changed: Canadian product import bans under Proclamations 11061, 11062, and 11063

CSMS #70050970 provides CBP's guidance on three presidential proclamations that exclude designated Canadian goods from entry into the United States. The proclamations are:

• Proclamation 11061: Excluding certain Canadian alcoholic beverages, issued in response to continued discrimination against U.S. commerce in alcoholic beverages.
• Proclamation 11062: Excluding certain Canadian products more broadly, also issued in response to continued discrimination against U.S. commerce.
• Proclamation 11063: A third related proclamation covering additional Canadian product categories under the same stated rationale.

These are import exclusions, not additional tariffs. Designated goods originating from Canada are barred from importation, meaning they cannot be entered for consumption or admitted to a Foreign Trade Zone under the standard admission procedures that would ordinarily apply.

New ACE and FTZ error codes for restricted Canadian goods

To enforce the proclamations in the Automated Commercial Environment, CBP has introduced new system error codes. CSMS #70050117 details these additions:

• ACE Cargo Release: New error codes will be generated when a restricted Canadian-origin product is presented for entry for consumption.
• e214 FTZ admissions: New error codes apply when a designated restricted product is submitted for FTZ admission.

Filers who receive these new error codes on Canadian-origin shipments should not attempt to re-file without first confirming that the specific HTS classification and product are not within the scope of the proclamations. The error codes are not system glitches; they are enforcement mechanisms.

Dates and applicability for Canadian restrictions

The restrictions apply to goods originating from Canada that are:

• Entered for consumption, or
• Withdrawn from a warehouse for consumption

on or after 12:01 a.m. Eastern Time on September 29, 2026. Goods already in a bonded warehouse that have not yet been withdrawn are caught by this date as well. The proclamations cover specific products under designated Harmonized Tariff Schedule provisions; consult CSMS #70050970 and the proclamations themselves for the precise HTS coverage.

Section 232 pharmaceutical tariffs: updated guidance under Proclamation 11020

CSMS #70054007 provides updated implementation guidance for Proclamation 11020, "Adjusting Imports of Pharmaceuticals and Pharmaceutical Ingredients Into the United States," dated April 2, 2026. The update incorporates a September 23, 2026 Federal Register notice that covers two matters:

• Guidance and procedures for specialty pharmaceuticals and associated pharmaceutical ingredients: CBP's updated procedures clarify how tariff adjustments are to be applied for these product categories under the Section 232 framework.
• Technical corrections to the Harmonized Tariff Schedule: The September 23 notice includes HTS technical corrections relevant to pharmaceutical entries. Importers who have been classifying pharma entries since April 2026 should compare their working classifications against the corrected HTS provisions at hts.usitc.gov.

Section 232 duties on pharmaceuticals apply in addition to any other applicable duties. Misclassification or failure to apply the correct Section 232 rate will result in underpayment of duties, creating potential penalty exposure and the need for post-entry corrections or protests.

Interaction with FTZ admissions and warehouse withdrawals

Both actions intersect with FTZ and bonded warehouse operations in important ways. For Canadian goods, the prohibition applies on withdrawal from warehouse for consumption as of September 29, 2026, meaning goods already bonded are not grandfathered. For pharmaceutical articles subject to Section 232, FTZ operators and importers should confirm that the updated HTS classifications and duty rates in the September 23 Federal Register notice are reflected in their admission and entry documentation going forward.

What importers, brokers, and compliance teams should do

• Review all pending and in-transit Canadian-origin shipments against the HTS provisions covered by Proclamations 11061, 11062, and 11063 before September 29, 2026, and place holds on warehouse withdrawals for any potentially restricted products pending classification review.
• Update ACE filing templates and FTZ admission procedures to account for the new error codes described in CSMS #70050117, and brief operations staff so that rejection notices are escalated immediately rather than re-filed without review.
• Cross-check all pharmaceutical and pharmaceutical-ingredient HTS classifications against the technical corrections published in the September 23, 2026 Federal Register notice, and correct any entries filed since April 2, 2026 that may be affected by the updated procedures under Proclamation 11020.

Key references

• CSMS #70050970: CBP guidance on Proclamations 11061, 11062, and 11063 excluding certain Canadian products from importation.
• CSMS #70050117: New ACE Cargo Release and e214 FTZ admission error codes for restricted Canadian-origin products, effective September 29, 2026.
• CSMS #70054007: Updated CBP guidance on Section 232 duties on pharmaceutical articles and ingredients under Proclamation 11020, incorporating the September 23, 2026 Federal Register notice.
• Federal Register: Search for the September 23, 2026 notice on specialty pharmaceutical tariff procedures and HTS technical corrections.
• Harmonized Tariff Schedule of the United States (USITC): Current HTS including technical corrections relevant to pharmaceutical entries.